Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BMS-986218
Trade Name
Synonyms BMS986218|BMS 986218
Drug Descriptions

BMS-986218 is a 2nd generation antibody that targets CTLA4, resulting in T-cell activation and increased anti-tumor immune response (AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr LB-B33).

DrugClasses CTLA4 Antibody 25 Immune Checkpoint Inhibitor 155
CAS Registry Number NA
NCIT ID C135633


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BMS-986218 BMS-986218 0 2
BMS-986218 + Degarelix BMS-986218 Degarelix 0 1
BMS-986218 + Docetaxel BMS-986218 Docetaxel 0 1
BMS-986218 + Docetaxel + Nivolumab BMS-986218 Docetaxel Nivolumab 0 1
BMS-986218 + Nivolumab BMS-986218 Nivolumab 0 3

Additional content available in CKB BOOST